Both Dr. Chiappella’s and Dr. Goy’s studies were supported in part by Celgene, maker of lenalidomide. Dr. Chiappella reported having no relevant disclosures. Dr. Goy is on Celgene’s speakers bureau.
AT THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY